Co-Authors
This is a "connection" page, showing publications co-authored by Giacomo De Riu and Carlos Chiesa-Estomba.
Connection Strength
0.858
-
Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients. Rhinology. 2021 Feb 01; 59(1):21-25.
Score: 0.232
-
Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study. J Laryngol Otol. 2020 Aug; 134(8):703-709.
Score: 0.224
-
Correction to: Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021 Aug; 278(8):2861.
Score: 0.060
-
Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study. Pathogens. 2021 Jun 04; 10(6).
Score: 0.059
-
Epidemiological, otolaryngological, olfactory and gustatory outcomes according to the severity of COVID-19: a study of 2579 patients. Eur Arch Otorhinolaryngol. 2021 Aug; 278(8):2851-2859.
Score: 0.058
-
Severity of Anosmia as an Early Symptom of COVID-19 Infection May Predict Lasting Loss of Smell. Front Med (Lausanne). 2020; 7:582802.
Score: 0.057
-
ACE2 & TMPRSS2 Expressions in Head & Neck Tissues: A Systematic Review. Head Neck Pathol. 2021 Mar; 15(1):225-235.
Score: 0.056
-
Clinical and Radiological Evaluations of COVID-19 Patients With Anosmia: Preliminary Report. Laryngoscope. 2020 11; 130(11):2526-2531.
Score: 0.056
-
Objective Olfactory Findings in Hospitalized Severe COVID-19 Patients. Pathogens. 2020 Jul 31; 9(8).
Score: 0.056